DE69123247D1 - Verfahren zur behandlung von alkoholsucht mit nalmefen - Google Patents

Verfahren zur behandlung von alkoholsucht mit nalmefen

Info

Publication number
DE69123247D1
DE69123247D1 DE69123247T DE69123247T DE69123247D1 DE 69123247 D1 DE69123247 D1 DE 69123247D1 DE 69123247 T DE69123247 T DE 69123247T DE 69123247 T DE69123247 T DE 69123247T DE 69123247 D1 DE69123247 D1 DE 69123247D1
Authority
DE
Germany
Prior art keywords
nalmefen
alcohol addiction
treating alcohol
treating
alcoholics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69123247T
Other languages
English (en)
Other versions
DE69123247T2 (de
Inventor
John Sinclair
Harry Scheinin
Risto Lammintausta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Contral Clinics Oy
Original Assignee
Alko Oy AB
Orion Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alko Oy AB, Orion Yhtyma Oy filed Critical Alko Oy AB
Application granted granted Critical
Publication of DE69123247D1 publication Critical patent/DE69123247D1/de
Publication of DE69123247T2 publication Critical patent/DE69123247T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
DE69123247T 1990-06-04 1991-05-10 Verfahren zur behandlung von alkoholsucht mit nalmefen Expired - Lifetime DE69123247T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/532,424 US5086058A (en) 1990-06-04 1990-06-04 Method for treating alcoholism with nalmefene
PCT/US1991/003241 WO1991018605A1 (en) 1990-06-04 1991-05-10 Method for treating alcoholism with nalmefene

Publications (2)

Publication Number Publication Date
DE69123247D1 true DE69123247D1 (de) 1997-01-02
DE69123247T2 DE69123247T2 (de) 1998-01-15

Family

ID=24121726

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69123247T Expired - Lifetime DE69123247T2 (de) 1990-06-04 1991-05-10 Verfahren zur behandlung von alkoholsucht mit nalmefen

Country Status (19)

Country Link
US (1) US5086058A (de)
EP (1) EP0531415B1 (de)
JP (1) JP3059213B2 (de)
AT (1) ATE145329T1 (de)
AU (1) AU642748B2 (de)
CA (1) CA2084519C (de)
DE (1) DE69123247T2 (de)
DK (1) DK0531415T3 (de)
ES (1) ES2097209T3 (de)
FI (1) FI925513A (de)
GR (1) GR3022289T3 (de)
HU (1) HU210637B (de)
IE (1) IE77333B1 (de)
LT (1) LT3893B (de)
LV (1) LV10190B (de)
NZ (1) NZ238391A (de)
RU (1) RU2090190C1 (de)
WO (1) WO1991018605A1 (de)
ZA (1) ZA914185B (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882335A (en) * 1988-06-13 1989-11-21 Alko Limited Method for treating alcohol-drinking response
US6271239B1 (en) * 1992-04-13 2001-08-07 Regents Of The University Of Minnesota Delta opioid receptor-selective benzylidene-substituted morphinans
US5352680A (en) * 1992-07-15 1994-10-04 Regents Of The University Of Minnesota Delta opioid receptor antagonists to block opioid agonist tolerance and dependence
USRE36547E (en) * 1992-09-21 2000-02-01 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists
US5580876A (en) * 1992-09-21 1996-12-03 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
US6096756A (en) * 1992-09-21 2000-08-01 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
US5298622A (en) * 1993-05-12 1994-03-29 Regents Of The University Of Minnesota Spiroindane opiate analogs
US5457208A (en) 1993-06-21 1995-10-10 Regents Of The University Of Minnesota Kappa opioid receptor antagonists
US5587381A (en) * 1995-03-27 1996-12-24 Sinclair; John D. Method for terminating methadone maintenance through extinction of the opiate-taking responses
WO1997018781A1 (en) * 1995-11-20 1997-05-29 University Of Miami Method of treating nicotine dependence
US5878750A (en) * 1996-11-14 1999-03-09 Clemens; Anton H. Method of treating the syndrome of coronary heart disease risk factors in humans
US5780479A (en) * 1997-04-04 1998-07-14 Regents Of The University Of Minnesota Use of opioid antagonists to treat impulse-control disorders
PT1685839E (pt) 1997-12-22 2013-07-08 Euro Celtique Sa Forma de dosagem farmacêutica por via oral compreendendo uma combinação de um agonista opióide e de um antagonista opióide
CA2314896C (en) 1997-12-22 2005-09-13 Euro-Celtique, S.A. A method of preventing abuse of opioid dosage forms
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
WO2001040269A2 (en) * 1999-11-30 2001-06-07 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
HUP0204163A2 (hu) 2000-02-08 2003-04-28 Euro-Celtique S.A. Opioid agonistát és antagonistát tartalmazó szabályozott leadású készítmény és eljárás az előállítására
US6716449B2 (en) 2000-02-08 2004-04-06 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
US20040024004A1 (en) * 2001-05-04 2004-02-05 Sherman Barry M. Novel compositions and methods for enhancing potency or reducing adverse side effects of opioid agonists
US6846831B2 (en) 2000-08-15 2005-01-25 Cpd, Llc Method of treating the syndrome of lipodystrophy
US6262062B1 (en) * 2000-08-15 2001-07-17 Cpd, Llc Method of treating the syndrome of coronary heart disease risk factors in humans
US6528520B2 (en) * 2000-08-15 2003-03-04 Cpd, Llc Method of treating the syndrome of coronary heart disease risk factors in humans
US20030065002A1 (en) 2001-05-11 2003-04-03 Endo Pharmaceuticals, Inc. Abuse-resistant controlled-release opioid dosage form
WO2003006980A1 (fr) * 2001-07-13 2003-01-23 Arkray, Inc. Appareil d'analyse, corps a element de perçage integralement installe pour un dispositif de mesure de la temperature associe a l'appareil d'analyse, et appareil de prelevement de liquide organique
PT1416842E (pt) * 2001-07-18 2009-03-31 Euro Celtique Sa Composições farmacêuticas de oxicodona e naloxona
PL367427A1 (en) 2001-08-06 2005-02-21 Euro-Celtique S.A. Opioid agonist formulations with releasable and sequestered antagonist
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US20030157168A1 (en) 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
WO2003015783A1 (en) * 2001-08-14 2003-02-27 Biotie Therapies Corporation Method of treating alcoholism or alcohol abuse
SI2425824T1 (sl) 2002-04-05 2017-06-30 Mundipharma Medical Cee Gmbh Farmacevtski pripravek, ki vsebuje oksikodon in nalokson
US7923454B2 (en) * 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7501433B2 (en) * 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
JP4668611B2 (ja) * 2002-05-31 2011-04-13 タイタン ファーマシューティカルズ インコーポレイテッド ブプレノルフィンの持続放出のための埋め込み型ポリマー製装置
HUE038446T2 (hu) 2002-09-20 2018-10-29 Alpharma Pharmaceuticals Llc Szekvesztráló alegység és releváns kompozíciók és módszerek
JP5064794B2 (ja) * 2003-03-31 2012-10-31 タイタン ファーマシューティカルズ インコーポレイテッド ドパミンアゴニストの徐放のための移植可能なポリマーデバイス
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
AU2004229551A1 (en) * 2003-04-14 2004-10-28 Pain Therapeutics, Inc. Methods for the treatment of pain comprising opioid antagonists
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US20060009478A1 (en) * 2003-10-15 2006-01-12 Nadav Friedmann Methods for the treatment of back pain
EP1604666A1 (de) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioide zur Behandlung der chronischen obstruktiven Lungenkrankheit
EP1702558A1 (de) * 2005-02-28 2006-09-20 Euro-Celtique S.A. Verfahren und Vorrichtung zur Darmtätigkeitserfassung
EP2484346B1 (de) * 2006-06-19 2017-02-22 Alpharma Pharmaceuticals LLC Pharmazeutische Zusammensetzungen
PT2724722T (pt) 2006-10-20 2017-03-14 Neurendo Pharma Llc Método de restaurar o efeito incretina
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US20100266645A1 (en) * 2007-12-17 2010-10-21 Alfred Liang Pharmaceutical compositions
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
ME01295B (me) * 2008-04-24 2012-08-31 Janssen Pharmaceutica Nv Prolijekovi nalfemen di-estera
RS52041B (en) * 2008-04-24 2012-04-30 Janssen Pharmaceutica N.V. NALMEPHENIC PRODUCTS
WO2010003963A1 (en) * 2008-07-07 2010-01-14 Euro-Celtique S.A. Use of opioid antagonists for treating urinary retention
PL2405915T3 (pl) 2009-03-10 2019-05-31 Euro Celtique Sa Kompozycje farmaceutyczne o natychmiastowym uwalnianiu zawierające oksykodon i nalokson
US20140005216A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations
WO2014170353A1 (en) * 2013-04-17 2014-10-23 H. Lundbeck A/S Nalmefene for treatment of patients with sleep disorder
KR20180037074A (ko) 2013-07-23 2018-04-10 유로-셀티큐 에스.에이. 장내 세균총이상을 초래하고/하거나 장내 박테리아 전위에 대한 위험을 증가시키는 질환과 통증으로 인해 고통받고 있는 환자에서 통증을 치료하는데 사용하기 위한 옥시코돈과 날록손의 조합물
AU2015250611A1 (en) * 2014-04-22 2016-11-24 H. Lundbeck A/S Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
US10034871B2 (en) 2014-11-07 2018-07-31 Regents Of The University Of Minnesota Salts and compositions useful for treating disease
CN117137917A (zh) * 2016-04-22 2023-12-01 景凯生物科技股份有限公司 纳美芬、纳曲酮或其衍生物在治疗(非)酒精性脂肪肝炎或非酒精性脂肪性肝病的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882335A (en) * 1988-06-13 1989-11-21 Alko Limited Method for treating alcohol-drinking response
US4857533A (en) * 1988-12-15 1989-08-15 Baker Cummins Pharmaceuticals, Inc. Method of treatment for autoimmune diseases
US4863928A (en) * 1989-01-04 1989-09-05 Baker Cummins Pharmaceuticals, Inc. Method of treatment for arthritic and inflammatory diseases
US5096715A (en) * 1989-11-20 1992-03-17 Alko Ltd. Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist

Also Published As

Publication number Publication date
IE77333B1 (en) 1997-12-03
CA2084519C (en) 1999-02-09
DK0531415T3 (da) 1996-12-09
CA2084519A1 (en) 1991-12-05
ZA914185B (en) 1992-07-29
HU9203835D0 (en) 1993-03-29
FI925513A0 (fi) 1992-12-04
ATE145329T1 (de) 1996-12-15
NZ238391A (en) 1997-06-24
LTIP1486A (en) 1995-09-25
LV10190A (lv) 1994-10-20
JPH06506665A (ja) 1994-07-28
DE69123247T2 (de) 1998-01-15
US5086058A (en) 1992-02-04
EP0531415A1 (de) 1993-03-17
FI925513A (fi) 1992-12-04
LV10190B (en) 1995-06-20
LT3893B (en) 1996-04-25
JP3059213B2 (ja) 2000-07-04
HUT65523A (en) 1994-06-28
RU2090190C1 (ru) 1997-09-20
AU7974091A (en) 1991-12-31
AU642748B2 (en) 1993-10-28
HU210637B (en) 1995-06-28
ES2097209T3 (es) 1997-04-01
WO1991018605A1 (en) 1991-12-12
EP0531415B1 (de) 1996-11-20
IE911888A1 (en) 1991-12-04
GR3022289T3 (en) 1997-04-30

Similar Documents

Publication Publication Date Title
ATE145329T1 (de) Verfahren zur behandlung von alkoholsucht mit nalmefen
RU92016403A (ru) Способ лечения алкоголизма налмефеном
DE69705218D1 (de) Verfahren zur herstellung von glinternden würfeleckigen retroflektierenden folien
DE69628938D1 (de) Verfahren zur herstellung synthetischer dieselbrennstoff
DE69431161T2 (de) Verfahren zur verbesserung von benzin
DE59603155D1 (de) Verfahren zur herstellung von hydrotalciten
DE60134590D1 (de) Verfahren zur Herstellung von kohlensäurehaltigem Wasser
DE59702613D1 (de) Verfahren zur herstellung von dienpolymerisatlösungen in vinylaromatischen monomeren
DE69628312D1 (de) Verfahren zur herstellung von getraenkedosenblech
ATE198531T1 (de) Verfahren zur herstellung von schwarzem instanttee
DE69026695D1 (de) Verfahren zur herstellung von hochfestem rostfreien bandstahl mit ausgezeichneten federeigenschaften
ATE204905T1 (de) Verfahren zur herstellung von äthylalkohol
DE59004541D1 (de) Verfahren zum Vermindern des Alkoholgehaltes alkoholischer Getränke.
DE557527T1 (de) Verfahren zur herstellung von hochoktanbenzin.
DE69021729T2 (de) Verfahren zur gewinnung von natürlich hergestelltem chymosin.
DE69111534T2 (de) Verfahren zur Herstellung von Alpha-Olefin durch Ethenolyse.
DE69615886T2 (de) Verfahren zur Wiedergabe von Filmen durch bidirektionale Kommunikation
DE58904843D1 (de) Verfahren zur entfernung von ethanol aus durch vergaerung erzeugten getraenken.
DE69410715T2 (de) Verfahren zur Herstellung von Harzen mit niedrigem Glanz
DE69703428D1 (de) Verfahren zur herstellung wässiger lösungen von tetraalkylammoniumhydroxiden
DE58904756D1 (de) Verfahren zur herstellung von tert.-amylalkohol (taa).
DE59104558D1 (de) Verfahren zur herstellung von konzentrierten wässrigen lösungen von anionischen azofarbstoffen.
DE3485006D1 (de) Verfahren zur herstellung von l-phenylalanin durch fermentation.
DE69625933T2 (de) Verfahren zur herstellung eines alkoholisches getränk durch fermentation und fermentationstestsatz zur durchführung des verfahrens
DE58902835D1 (de) Verfahren zur herstellung von schaumwein.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: CONTRAL CLINICS OY, ESPOO, FI

8364 No opposition during term of opposition